Filing Details
- Accession Number:
- 0001415889-24-011662
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-04-29 16:30:19
- Reporting Period:
- 2024-04-25
- Accepted Time:
- 2024-04-29 16:30:19
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1082554 | United Therapeutics Corp | UTHR | Pharmaceutical Preparations (2834) | 521984749 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1106578 | A Martine Rothblatt | C/O United Therapeutics Corporation 1000 Spring Street Silver Spring MD 20910 | Chairperson & Ceo | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-04-25 | 3,600 | $129.49 | 3,730 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-04-25 | 2,056 | $235.02 | 1,674 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-04-25 | 1,203 | $236.04 | 471 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-04-25 | 341 | $236.84 | 130 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2024-04-26 | 3,600 | $129.49 | 3,730 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-04-26 | 835 | $234.36 | 2,895 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-04-26 | 2,271 | $235.23 | 624 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-04-26 | 417 | $236.34 | 207 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-04-26 | 77 | $237.00 | 130 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options | Disposition | 2024-04-25 | 3,600 | $0.00 | 3,600 | $129.49 |
| Common Stock | Stock Options | Disposition | 2024-04-26 | 3,600 | $0.00 | 3,600 | $129.49 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 299,069 | 2014-12-31 | 2024-12-31 | No | 4 | M | Direct |
| 295,469 | 2014-12-31 | 2024-12-31 | No | 4 | M | Direct |
Footnotes
- This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.
- This transaction was executed in multiple trades at prices ranging from $234.495 to $235.49. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $235.525 to $236.48. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $236.615 to $237.045. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $233.79 to $234.67. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $234.80 to $235.795. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $235.81 to $236.67. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Billionaire Hedge Funds
